General Information Document Type: Presolicitation Synopsis Number: 75N98026Q00647 Posted Date: June 17, 2026 Original Response Date: June 29, 2026 Current Response Date: June 29, 2026 Set Aside: N/A NAICS Code: 541990 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Children's Research Institute 111 Michigan Ave NW Washington, DC 20010-2916 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541990 with a Size Standard $. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Young At Heart Type 2 Diabetes Research Longitudinal Protocol between Children's National Hospital (CNH) and NIDDK Background Information: Youth-onset type 2 diabetes (T2D) is a rapidly progressive, debilitating disease that is associated with early-onset micro- and macrovascular complications. The rate of disease progression and the natural history of subclinical atherosclerosis in T2D youth remains to be elucidated. The joint CNH/ NIDDK Y-T2DM program investigates metabolic mechanisms of diabetes risk and management in youth, and young adults. We are conducting a multi-site study with Children's National Hospital as a site to evaluate risk for heart disease and in youth. The protocol is registered on clinicaltrials.gov (NCT06730113) and has received regulatory approval. A research collaboration agreement is being processed to support research activities and coordination between CNH and the National Institutes of Health Clinical Center (NIH CC). CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capabi…